Table 4.
Patients | Timing of First MDS Assessment Relative to the Date of Cancer Diagnosis (%) | Median time from DX to first MDS assessment | ||||||
---|---|---|---|---|---|---|---|---|
Cancer site | N | 1+ months before (%) | Month of or 1 month after (%) | 2–12 months after (%) | 13–36 months after (%) | 37–60 months after (%) | 60+ months after (%) | Months |
Bladder | 14090 | 9.1 | 7.5 | 15.0 | 21.2 | 18.4 | 28.8 | 33 |
Breast | 36044 | 7.6 | 3.1 | 8.8 | 20.7 | 21.3 | 38.6 | 48 |
Colorectal | 28485 | 9.6 | 18.1 | 13.5 | 15.7 | 15.7 | 27.4 | 26 |
Kidney | 7726 | 10.2 | 12.7 | 13.4 | 18.7 | 17.0 | 28.1 | 30 |
Leukemias | 5860 | 13.8 | 12.1 | 14.3 | 18.7 | 16.1 | 25.0 | 25 |
Lung | 28490 | 16.3 | 20.1 | 24.2 | 18.1 | 9.8 | 11.5 | 6 |
Non-hodgkin lymphoma | 10713 | 8.9 | 12.9 | 15.6 | 18.1 | 16.6 | 27.9 | 30 |
Ovary | 2917 | 12.4 | 23.9 | 17.1 | 16.0 | 13.3 | 17.3 | 9 |
Pancreas | 4681 | 25.8 | 27.9 | 27.8 | 10.5 | 3.7 | 4.3 | 1 |
Prostate | 31884 | 5.1 | 2.8 | 7.1 | 18.5 | 21.4 | 45.2 | 55 |
Thyroid | 2117 | 8.7 | 4.2 | 10.5 | 18.6 | 19.7 | 38.3 | 46 |
Uterus/Endometrium | 7895 | 8.6 | 8.5 | 14.7 | 20.1 | 17.0 | 31.3 | 34 |
Other Cancer | 67201 | 12.9 | 13.3 | 17.3 | 19.3 | 15.1 | 22.0 | 19 |
Multiple- first cancer | 8844 | 7.9 | 11.2 | 21.0 | 20.2 | 16.0 | 23.7 | 23 |
Note. DX=Diagnosis; MDS=Minimum Data Set